Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

Go back to Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology
(NASDAQ: NRIX) Delayed: 18.65 --0 (-0%)
Previous Close $18.65    52 Week High
Open $18.65    52 Week Low
Day High $18.65    P/E N/A 
Day Low $18.65    EPS
Volume 1,627       

Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 49.12 --0 (-0%)
Previous Close $49.12    52 Week High $35.13 
Open $49.12    52 Week Low $28.10 
Day High $49.12    P/E N/A 
Day Low $49.12    EPS $0.00 
Volume 1,305       

Brown & Brown, Inc. (NYSE: RO) Delayed: 8.49 +0.55 (6.93%)
Previous Close $7.94    52 Week High $8.59 
Open $7.94    52 Week Low $7.82 
Day High $8.59    P/E 6.53 
Day Low $7.82    EPS $1.30 
Volume 42,732       

Roper Industries (NASDAQ: ROP) Delayed: 325.09 --0 (-0%)
Previous Close $325.09    52 Week High $195.93 
Open $325.09    52 Week Low $155.79 
Day High $325.09    P/E 60.54 
Day Low $325.09    EPS $5.37 
Volume 952